Molecular Data Performance
| MKDTYDelisted Stock | USD 0.01 0.01 2,567% |
The company secures a Beta (Market Risk) of -5.19, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Molecular Data are expected to decrease by larger amounts. On the other hand, during market turmoil, Molecular Data is expected to outperform it. Molecular Data right now secures a risk of 0.0%. Please verify Molecular Data maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Molecular Data will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Molecular Data has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Molecular Data is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Molecular |
Molecular Data Relative Risk vs. Return Landscape
If you would invest 0.80 in Molecular Data on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Molecular Data or generate 0.0% return on investment over 90 days. Molecular Data is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Molecular, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Molecular Data Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Molecular Data's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Molecular Data, and traders can use it to determine the average amount a Molecular Data's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MKDTY |
Based on monthly moving average Molecular Data is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Molecular Data by adding Molecular Data to a well-diversified portfolio.
About Molecular Data Performance
Evaluating Molecular Data's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Molecular Data has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Molecular Data has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Molecular Data performance evaluation
Checking the ongoing alerts about Molecular Data for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Molecular Data help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Molecular Data is not yet fully synchronised with the market data | |
| Molecular Data has some characteristics of a very speculative penny stock | |
| Molecular Data has a very high chance of going through financial distress in the upcoming years |
- Analyzing Molecular Data's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Molecular Data's stock is overvalued or undervalued compared to its peers.
- Examining Molecular Data's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Molecular Data's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Molecular Data's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Molecular Data's pink sheet. These opinions can provide insight into Molecular Data's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Molecular Pink Sheet
If you are still planning to invest in Molecular Data check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molecular Data's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |